Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

Hardingham, Giles E., Bading, Hilmar·2010·Nature Reviews Neuroscience

Cited by (1,001)

Items 201–300 of 1,001

  1. Aquaporin-4 Deficiency Impairs Synaptic Plasticity and Associative Fear Memory in the Lateral Amygdala: Involvement of Downregulation of Glutamate Transporter-1 Expression
    Yankun Li, Fang Wang, Wei Wang, Yi Luo, Peng-Fei Wu, Jun‐Li Xiao, Zhuang‐Li Hu, You Jin, Gang Hu, Jianguo Chen · 2012 · Neuropsychopharmacology
  2. RETRACTED: The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation
    Fatou Amar, Mathew A. Sherman, Travis Rush, Megan E. Larson, Gabriel E. Boyle, Chang Liu, Jürgen Götz, Alain Buisson, Sylvain Lesné · 2017 · Science Signaling · Retracted
  3. Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia
    Ebrahim Haroon, Xiangchuan Chen, Zhihao Li, Thrusharth Patel, Bobbi J. Woolwine, Xiaoping Philip Hu, Jennifer C. Felger, Andrew H. Miller · 2018 · Translational Psychiatry
  4. Conjugation of Peptides to the Passivation Shell of Gold Nanoparticles for Targeting of Cell-Surface Receptors
    Lisa Maus, Oliver Dick, Hilmar Bading, Joachim P. Spatz, Roberto Fiammengo · 2010 · ACS Nano
  5. Calcium-Binding Proteins as Determinants of Central Nervous System Neuronal Vulnerability to Disease
    Richard Fairless, Sarah K. Williams, Ricarda Diem · 2019 · International Journal of Molecular Sciences
  6. Perinatal brain damage: The term infant
    Henrik Hagberg, Anthony David Edwards, Floris Groenendaal · 2015 · Neurobiology of Disease
  7. l-Serine links metabolism with neurotransmission
    Marianne Maugard, Pierre-Antoine Vigneron, Juan Pedro Bolaños, Gilles Bonvento · 2020 · Progress in Neurobiology
  8. Cannabidiol for neurodegenerative disorders: A comprehensive review
    Sukanya Bhunia, Nagesh Kolishetti, Adriana Yndart, Arti Vashist, Madhavan G. Nair · 2022 · Frontiers in Pharmacology
  9. Modulation of NMDAR Subunit Expression by TRPM2 Channels Regulates Neuronal Vulnerability to Ischemic Cell Death
    Ishraq Alim, Lucy M Teves, Rongwen Li, Yasuo Mori, Michael Tymianski · 2013 · Journal of Neuroscience
  10. Curcumin in Depression: Potential Mechanisms of Action and Current Evidence—A Narrative Review
    Tahiana Ramaholimihaso, Fayçal Bouazzaoui, Arthur Kaladjian · 2020 · Frontiers in Psychiatry
  11. Roles of Selenoproteins in Brain Function and the Potential Mechanism of Selenium in Alzheimer’s Disease
    Zhong-Hao Zhang, Guo-Li Song · 2021 · Frontiers in Neuroscience
  12. Ketamine in neuropsychiatric disorders: an update
    Johnston, Jenessa N., Kadriu, Bashkim, Kraus, Christoph, Henter, Ioline D., Zarate, Carlos A. · 2024 · Neuropsychopharmacology
  13. Main path and byways: non‐vesicular glutamate release by system xc−as an important modifier of glutamatergic neurotransmission
    Ann Massie, Séverine Boillée, Sandra J. Hewett, Lori A. Knackstedt, Jan Lewerenz · 2015 · Journal of Neurochemistry
  14. Functional coupling of TRPM2 and extrasynaptic NMDARs exacerbates excitotoxicity in ischemic brain injury
    Pengyu Zong, Jianlin Feng, Zhichao Yue, Yunfeng Li, Gongxiong Wu, Baonan Sun, Yanlin He, Barbara A. Miller, Albert S. Yu, Zhongping Su et al. · 2022 · Neuron
  15. GluN2B subunit deletion reveals key role in acute and chronic ethanol sensitivity of glutamate synapses in bed nucleus of the stria terminalis
    Wills, Tiffany A., Klug, Jason R., Silberman, Yuval, Baucum, Anthony J., Weitlauf, Carl, Colbran, Roger J., Delpire, Eric, Winder, Danny G. · 2012 · Proceedings of the National Academy of Sciences
  16. Knocking down of the KCC2 in rat hippocampal neurons increases intracellular chloride concentration and compromises neuronal survival
    Christophe Pellegrino, Olena Gubkina, Michael Schaefer, Hélène Becq, Anastasia Ludwig, Marat R. Mukhtarov, Ilona Chudotvorova, Séverine Corby, Yuriy Tarasovych Salyha, Sergey V. Salozhin et al. · 2011 · The Journal of Physiology
  17. Hippocampal Adult Neurogenesis Is Maintained by Neil3-Dependent Repair of Oxidative DNA Lesions in Neural Progenitor Cells
    Christine Elisabeth Regnell, Gunn A. Hildrestrand, Yngve Sejersted, Tirill Medin, Olve Moldestad, Veslemøy Rolseth, Silje Zandstra Krokeide, Rajikala Suganthan, Luisa Luna, Magnar Bjørås et al. · 2012 · Cell Reports
  18. Glutamate receptors in preclinical research on Alzheimer's disease: Update on recent advances
    Neng‐Wei Hu, Tomáš Ondrejčák, Michael J. Rowan · 2011 · Pharmacology Biochemistry and Behavior
  19. Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization
    Nathan G. Glasgow, Nadezhda V. Povysheva, Andrea M. Azofeifa, Jon W. Johnson · 2017 · Journal of Neuroscience
  20. Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine’s Antidepressant Effect
    Wenyan Cui, Yuping Ning, Wu Hong, Ju Wang, Zhening Liu, Ming D. Li · 2018 · Molecular Neurobiology
  21. Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome
    Gerwyn Morris, Michael Berk, Hans Christiaan Klein, Ken R. Walder, Piotr Gałecki, Michael H. J. Maes · 2016 · Molecular Neurobiology
  22. Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effects
    S-X Li, Ying Han, Lingzhi Xu, Kai Yuan, R-X Zhang, C-Y Sun, D-F Xu, M Yuan, J-H Deng, S-Q Meng et al. · 2017 · Molecular Psychiatry
  23. Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture
    Takashi Miyamoto, Liana Roberts Stein, Reuben Thomas, Biljana Djukic, Praveen Taneja, Joseph A. Knox, Keith A. Vossel, Lennart Mucke · 2017 · Molecular Neurodegeneration
  24. Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration
    Christine D. Pozniak, Arundhati Sengupta Ghosh, Alvin Gogineni, Jesse E. Hanson, Seung-Hye Lee, Jessica L. Larson, Hilda O. Solanoy, Daisy J. Bustos, Hong Li, Hai Ngu et al. · 2013 · The Journal of Experimental Medicine
  25. MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers
    Wei, Wei, Wang, Zhi-Yong, Ma, Li-Na, Zhang, Ting-Ting, Cao, Yu, Li, Hao · 2020 · Frontiers in Molecular Neuroscience
  26. Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer’s disease
    Dawn C. Matthews, Xiangling Mao, Kathleen Dowd, Diamanto Tsakanikas, Caroline S. Jiang, Caroline Meuser, Randolph D. Andrews, Ana S Lukic, Jihyun Lee, Nicholas Henry Hampilos et al. · 2021 · Brain
  27. What We Know and Would Like to Know about CDKL5 and Its Involvement in Epileptic Encephalopathy
    Charlotte Kilstrup‐Nielsen, Laura Rusconi, Paolo La Montanara, Dalila Ciceri, Anna Bergo, Francesco Bedogni, Nicoletta Landsberger · 2012 · Neural Plasticity
  28. Glutamate as a Neurotransmitter
    Steven J. Mennerick, Charles F. Zorumski · 2012 · Wiley eBooks
  29. Time and space profiling of NMDA receptor co‐agonist functions
    Jean‐Pierre Mothet, Matildé Le Bail, Jean‐Marie Billard · 2015 · Journal of Neurochemistry
  30. Advances in non-dopaminergic treatments for Parkinson's disease
    Sandy Stayte, Bryce Vissel · 2014 · Frontiers in Neuroscience
  31. Therapy development in Huntington disease: From current strategies to emerging opportunities
    Audrey S. Dickey, Albert R. La Spada · 2017 · American Journal of Medical Genetics Part A
  32. Nuclear Calcium-VEGFD Signaling Controls Maintenance of Dendrite Arborization Necessary for Memory Formation
    Daniela Mauceri, H. Eckehard Freitag, Ana M.M. Oliveira, C. Peter Bengtson, Hilmar Bading · 2011 · Neuron
  33. The Relationship Between Glutamate Dynamics and Activity-Dependent Synaptic Plasticity
    Barnes, Jocelyn R., Mukherjee, Bandhan, Rogers, Ben C., Nafar, Firoozeh, Gosse, Madeline, Parsons, Matthew P. · 2020 · The Journal of Neuroscience
  34. Building a Bridge Between NMDAR-Mediated Excitotoxicity and Mitochondrial Dysfunction in Chronic and Acute Diseases
    Rodrigo G. Mira, Waldo F. Cerpa · 2020 · Cellular and Molecular Neurobiology
  35. Zika Virus Promotes Neuronal Cell Death in a Non-Cell Autonomous Manner by Triggering the Release of Neurotoxic Factors
    Isabella Guimarães Olmo, Toniana G. Carvalho, Vivian Vasconcelos Costa, Juliana Alves‐Silva, Carolina Zaniboni Ferrari, Tatiane C. Izidoro‐Toledo, Juliana da Silva, Antônio Lúcio Teixeira, Danielle G. Souza, João Trindade Marques et al. · 2017 · Frontiers in Immunology
  36. NMDARs in Cell Survival and Death: Implications in Stroke Pathogenesis and Treatment
    Yang Ge, Wenlin Chen, Peter Axerio-Cilies, Yu Tian Wang · 2020 · Trends in Molecular Medicine
  37. Glutamate and Mitochondria: Two Prominent Players in the Oxidative Stress-Induced Neurodegeneration
    Tommaso Cassano, Lorenzo Pace, Gaurav Bedse, Angelo Michele Lavecchia, Federico De Marco, Silvana Gaetani, Gaetano Serviddio · 2015 · Current Alzheimer Research
  38. Glutamate excitotoxicity and Ca 2+ -regulation of respiration: Role of the Ca 2+ activated mitochondrial transporters (CaMCs)
    Carlos B. Rueda, Irene Llorente‐Folch, Javier Traba, Ignácio Amigo, Paloma González‐Sánchez, Laura Contreras, Inés Juaristi, Paula Martínez-Valero, Beatriz Pardo, Araceli del Arco et al. · 2016 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
  39. Nuclear Calcium Signaling
    C. Peter Bengtson, Hilmar Bading · 2012 · Advances in experimental medicine and biology
  40. Perspectives on neuroinflammation and excitotoxicity: A neurotoxic conspiracy?
    Barbara Viviani, Mariaserena Boraso, Natalia Marchetti, Marina Marinovich · 2014 · NeuroToxicology
  41. Central role for NMDA receptors in redox mediated impairment of synaptic function during aging and Alzheimer’s disease
    Thomas C. Foster, C. Kyritsopoulos, Ashok Kumar · 2016 · Behavioural Brain Research
  42. Diverse modes of NMDA receptor positive allosteric modulation: Mechanisms and consequences
    David H. Hackos, Jesse E. Hanson · 2016 · Neuropharmacology
  43. Impact of Ketamine on Neuronal Network Dynamics: Translational Modeling of Schizophrenia‐Relevant Deficits
    Bernát Kocsis, Ritchie Edward Brown, Robert W. McCarley, Mihály Hajós · 2013 · CNS Neuroscience & Therapeutics
  44. Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction
    Nicholas L. Weilinger, Valentyna Maslieieva, Jennifer Bialecki, Sarup S. Sridharan, Peter L. Tang, Roger J. Thompson · 2012 · Acta Pharmacologica Sinica
  45. Striatal synaptic dysfunction and altered calcium regulation in Huntington disease
    Lynn A. Raymond · 2016 · Biochemical and Biophysical Research Communications
  46. Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer’s molecular signatures
    Sharma, Abhijeet, Kazim, Syed Faraz, Larson, Chloe S., Ramakrishnan, Aarthi, Gray, Jason D., McEwen, Bruce S., Rosenberg, Paul A., Shen, Li, Pereira, Ana C. · 2019 · Proceedings of the National Academy of Sciences
  47. 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival
    Min‐Yu Sun, Andrew J. Linsenbardt, Christine M. Emnett, Lawrence N. Eisenman, Yukitoshi Izumi, Charles F. Zorumski, Steven J. Mennerick · 2015 · The Neuroscientist
  48. Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
    Lucy E Farrimond, Emmert Roberts, Rupert H. McShane · 2012 · BMJ Open
  49. Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease
    Audrey Hector, Jonathan Brouillette · 2021 · Frontiers in Molecular Neuroscience
  50. Noxious Stimulation Attenuates Ketamine-induced Neuroapoptosis in the Developing Rat Brain
    Jia Liu, Qian Liu, Jing Li, Chong Wha Baek, Xiao Han, Umeshkumar Athiraman, Sulpicio G. Soriano · 2012 · Anesthesiology
  51. FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801
    Fuminori Yamaguchi, Yuko Hirata, Hossain Akram, Kazuyo Kamitori, Youyi Dong, Li Sui, Masaaki Tokuda · 2013 · BMC Cancer
  52. Mechanical stress activates NMDA receptors in the absence of agonists
    Mohammad Mehdi Maneshi, Bruce A. Maki, Radhakrishnan Gnanasambandam, Sophie Belin, Gabriela Popescu, Frederick Sachs, Susan Z. Hua · 2017 · Scientific Reports
  53. Functions of intrinsic disorder in transmembrane proteins
    Magnus Kjærgaard, Birthe Brandt Kragelund · 2017 · Cellular and Molecular Life Sciences
  54. Obesity as a Risk Factor for Alzheimer’s Disease: Implication of Leptin and Glutamate
    Ana Lloret, Paloma Monllor, Daniel Esteve, Ana Cervera‐Ferri, María-Ángeles Lloret · 2019 · Frontiers in Neuroscience
  55. The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research
    Meysam Amidfar, Marie Woelfer, Gislaine Z. Réus, João Quevedo, Martin Walter, Yong‐Ku Kim · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  56. NMDA receptors
    Eduardo Elias Benarroch · 2011 · Neurology
  57. Antagonism of purinergic signalling improves recovery from traumatic brain injury.
    A. Choo, W. Miller, Y. Chen, Philip D. Nibley, Tapan P. Patel, C. Goletiani, B. Morrison, Melinda K. Kutzing, B. Firestein, J. Sul et al. · 2013 · Brain : a journal of neurology
  58. Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
    A. Y. Kim, Salman Al Jerdi, R. MacDonald, Chris R. Triggle · 2024 · Frontiers in Pharmacology
  59. Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia
    Zhihong Jiang, Rita Marie Cowell, Kazu Nakazawa · 2013 · Frontiers in Behavioral Neuroscience
  60. Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer’s Disease
    Mikael Marttinen, Mari Takalo, Teemu Natunen, Rebekka Wittrahm, Sami Gabbouj, Susanna Kemppainen, Ville Leinonen, Heikki Tanila, Annakaisa Haapasalo, Mikko O. Hiltunen · 2018 · Frontiers in Neuroscience
  61. Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology
    Madeeha Nasir, Daniel Trujillo, Jessica L.S. Levine, Jennifer B. Dwyer, Zachary W. Rupp, Michael H. Bloch · 2020 · Frontiers in Psychiatry
  62. Biological Mechanisms of Cancer-Induced Depression
    Kimberly Young, Gurmit Singh · 2018 · Frontiers in Psychiatry
  63. Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties
    Bruno P. Meloni, Diego Milani, Adam B. Edwards, Ryan S. Anderton, Ryan O’Hare Doig, Melinda Fitzgerald, T. Norman Palmer, Neville W. Knuckey · 2015 · Pharmacology & Therapeutics
  64. The brain as immunoprecipitator of serum autoantibodies against N‐Methyl‐D‐aspartate receptor subunit NR1
    Castillo‐Gomez, Esther, Kästner, Anne, Steiner, Johann, Schneider, Anja, Hettling, Bilke, Poggi, Giulia, Ostehr, Kristin, Uhr, Manfred, Asif, Abdul R., Matzke, Mike et al. · 2016 · Annals of Neurology
  65. Discovery and development of NA-1 for the treatment of acute ischemic stroke
    Beatrice Ballarin, Michael Tymianski · 2018 · Acta Pharmacologica Sinica
  66. Novel Therapeutic Approach for Excitatory/Inhibitory Imbalance in Neurodevelopmental and Neurodegenerative Diseases
    Swagata Ghatak, Maria V. Talantova, Scott R. McKercher, Stuart A. Lipton · 2020 · The Annual Review of Pharmacology and Toxicology
  67. NMDA receptor-dependent glutamate excitotoxicity in human embryonic stem cell-derived neurons
    Kunal Gupta, Giles E. Hardingham, Siddharthan Chandran · 2013 · Neuroscience Letters
  68. Retinal Glutamate Neurotransmission: From Physiology to Pathophysiological Mechanisms of Retinal Ganglion Cell Degeneration
    Isabella Boccuni, Richard Fairless · 2022 · Life
  69. Ion channels and channelopathies in glomeruli
    Alexander Staruschenko, Rong Ma, Oleg Palygin, Stuart E. Dryer · 2022 · Physiological Reviews
  70. Nitric Oxide in the Nervous System
    Marcelo Cossenza, Renato Socodato, Camila Cabral Portugal, Ivan Domith, Luis Gladulich, Thaísa Godinho da Encarnação, Karin da Costa Calaza, Henrique Rocha Mendonça, Paula Campello‐Costa, Roberto Paes‐de‐Carvalho · 2014 · Vitamins and hormones
  71. Interaction of metal ions with neurotransmitter receptors and potential role in neurodiseases
    Carla Marchetti · 2014 · BioMetals
  72. ER to synapse trafficking of NMDA receptors
    Martin Hořák, Ronald S. Petralia, Martina Kaniaková, Nathalie Sans · 2014 · Frontiers in Cellular Neuroscience
  73. Neuroprotective Mechanisms of Lycium barbarum Polysaccharides Against Ischemic Insults by Regulating NR2B and NR2A Containing NMDA Receptor Signaling Pathways
    Zhongshan Shi, Lihui Zhu, Tingting Li, Xiaoya Tang, Yonghui Xiang, Xinjia Han, Luoxing Xia, Ling Zeng, Jun‐Hua Nie, Yongxia Huang et al. · 2017 · Frontiers in Cellular Neuroscience
  74. Role of glutamate receptors and glial cells in the pathophysiology of treatment-resistant depression
    Kim, Yong-Ku, Na, Kyoung-Sae · 2016 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  75. A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists
    Wenwu Liu, Xiaowen Jiang, Yuxin Zu, Yang Yue, Yaqian Liu, Xue Sun, Zihua Xu, Huaiwei Ding, Qingchun Zhao · 2020 · European Journal of Medicinal Chemistry
  76. Excitation–transcription coupling, neuronal gene expression and synaptic plasticity
    Huan Ma, Houda G. Khaled, Xiaohan Wang, Nataniel J. Mandelberg, Samuel M. Cohen, Xingzhi He, Richard W. Tsien · 2023 · Nature reviews. Neuroscience
  77. Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology
    Cai, Wenwen, Li, Linxi, Sang, Shaoming, Pan, Xiaoli, Zhong, Chunjiu · 2023 · Neuroscience Bulletin
  78. Modes of Aβ toxicity in Alzheimer’s disease
    Jürgen Götz, Anne Eckert, Miriam Matamales, Lars Matthias Ittner, Xin Liu · 2011 · Cellular and Molecular Life Sciences
  79. DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
    Shan Wang, Xiang-de Shi, Hao Li, Pei Pang, Lei Pei, Huiyong Shen, Youming Lu · 2016 · Molecular Neurobiology
  80. Ketamine: Neuroprotective or Neurotoxic?
    Divya Choudhury, Anita E. Autry, Kimberley F. Tolias, Vaishnav Krishnan · 2021 · Frontiers in Neuroscience
  81. A novel environment-evoked transcriptional signature predicts reactivity in single dentate granule neurons
    Baptiste N. Jaeger, Sara B. Linker, Sarah Parylak, Jerika J. Barron, Iryna S. Gallina, Christian D Saavedra, Conor Fitzpatrick, Christina K. Lim, Simon T. Schafer, Benjamin Lacar et al. · 2018 · Nature Communications
  82. Calpain and STriatal-Enriched protein tyrosine Phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model
    Clare M. Gladding, Marja D. Sepers, J. Xu, Lily Y. J. Zhang, Austen J. Milnerwood, Paul J. Lombroso, Lynn A. Raymond · 2012 · Human Molecular Genetics
  83. Macromolecular transport in synapse to nucleus communication
    Nicolas Panayotis, Anna Karpova, Michael R. Kreutz, Mike Fainzilber · 2014 · Trends in Neurosciences
  84. Comparative Impact of Voltage-Gated Calcium Channels and NMDA Receptors on Mitochondria-Mediated Neuronal Injury
    Stanika, Ruslan I., Villanueva, Idalis, Kazanina, Galina, Andrews, S. Brian, Pivovarova, Natalia B. · 2012 · The Journal of Neuroscience
  85. α7 Nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect
    Huiyang Liu, Xiaomei Zhang, Peng Shi, Ji-Yuan Yuan, Qiang Jia, Chao Pi, Tao Chen, Linjin Xiong, Jinglin Chen, Jia Tang et al. · 2023 · Journal of Neuroinflammation
  86. Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice
    Alejandro Dau, Clare M. Gladding, Marja D. Sepers, Lynn A. Raymond · 2013 · Neurobiology of Disease
  87. The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia
    Diana C. Rotaru, David A. Lewis, Guillermo González‐Burgos · 2012 · Reviews in the Neurosciences
  88. Neurotoxicity of lead. Hypothetical molecular mechanisms of synaptic function disorders
    Irena Baranowska‐Bosiacka, Izabela Gutowska, Marta Rybicka, Przemysław Nowacki, Dariusz Chlubek · 2012 · Neurologia i Neurochirurgia Polska
  89. Molecular pharmacology of human NMDA receptors
    Maiken K. Hedegaard, Kasper Bø Hansen, Karen T. Andersen, Hans Bräuner‐Osborne, Stephen F. Traynelis · 2011 · Neurochemistry International
  90. Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi
    Li-Ze Gu, Baosheng Huang, Wei Shen, Li Gao, ZhengZheng Ding, Hui‐Wen Wu, Jun Guo · 2013 · Journal of Neuroinflammation
  91. A family of photoswitchable NMDA receptors
    Shai Berlin, Stephanie Szobota, Andreas Reiner, Elizabeth C. Carroll, Michael A. Kienzler, Alice Guyon, Tong Xiao, Dirk H. Trauner, Ehud Y. Isacoff · 2016 · eLife
  92. Modulation of Neocortical Development by Early Neuronal Activity: Physiology and Pathophysiology
    Sergei Kirischuk, Anne Sinning, Oriane Blanquie, Jenq‐Wei Yang, Heiko J. Luhmann, Werner Kilb · 2017 · Frontiers in Cellular Neuroscience
  93. Extrasynaptic CaMKIIα is involved in the antidepressant effects of ketamine by downregulating GluN2B receptors in an LPS-induced depression model
    Xiao-Hui Tang, Guang-Fen Zhang, Ning Xu, Guifang Duan, Min Jia, Ru Liu, Zhiqiang Zhou, Jianjun Yang · 2020 · Journal of Neuroinflammation
  94. Consolidation and translation regulation: Figure 1.
    Shunit Gal-Ben-Ari, Justin W. Kenney, Hadile Ounalla-Saad, Elham Taha, Orit David, David Levitan, Iness Gildish, Debabrata Panja, Balagopal Pai, Karin Wibrand et al. · 2012 · Learning & Memory
  95. Amyloid, APP, and Electrical Activity of the Brain
    Dimitri Hefter, Susann Ludewig, Andreas Draguhn, Martin Körte · 2019 · The Neuroscientist
  96. Harnessing Brain Plasticity: The Therapeutic Power of Repetitive Transcranial Magnetic Stimulation (rTMS) and Theta Burst Stimulation (TBS) in Neurotransmitter Modulation, Receptor Dynamics, and Neuroimaging for Neurological Innovations
    Minoo Sharbafshaaer, Giovanni Cirillo, Fabrizio Esposito, Gioacchino Tedeschi, Francesca Trojsi · 2024 · Biomedicines
  97. Update on the Neuroprotective Effect of Estrogen Receptor Alpha Against Alzheimer's Disease
    Yu‐Long Lan, Jie Zhao, Shao Li · 2014 · Journal of Alzheimer s Disease
  98. N-Methyl-d-aspartate Receptor Mechanosensitivity Is Governed by C Terminus of NR2B Subunit
    Pallab K. Singh, Shachee Doshi, Jennifer M. Spaethling, Adam J. Hockenberry, Tapan P. Patel, Donna M. Geddes‐Klein, David R. Lynch, David F. Meaney · 2011 · Journal of Biological Chemistry
  99. p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer’s disease
    Arne Ittner, Amadeus Gladbach, Josefine Bertz, Lisa S. Suh, Lars Matthias Ittner · 2014 · Acta Neuropathologica Communications
  100. A New Vision for Therapeutic Hypothermia in the Era of Targeted Temperature Management: A Speculative Synthesis
    Travis C. Jackson, Patrick Michael Kochanek · 2019 · Therapeutic Hypothermia and Temperature Management